201 related articles for article (PubMed ID: 16714425)
1. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial.
Ridker PM; Danielson E; Rifai N; Glynn RJ;
Hypertension; 2006 Jul; 48(1):73-9. PubMed ID: 16714425
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
Everett BM; Glynn RJ; Danielson E; Ridker PM;
Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.
Tuomilehto J; Tykarski A; Baumgart P; Reimund B; Le Breton S; Ferber P
Blood Press Suppl; 2008 Jun; 1():15-23. PubMed ID: 18705531
[TBL] [Abstract][Full Text] [Related]
6. Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy.
Weinberger MH; Glazer RD; Crikelair NA; Chiang YT
J Hum Hypertens; 2010 Dec; 24(12):823-30. PubMed ID: 20182456
[TBL] [Abstract][Full Text] [Related]
7. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
[TBL] [Abstract][Full Text] [Related]
8. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
[TBL] [Abstract][Full Text] [Related]
9. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
11. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial.
Conen D; Everett BM; Glynn RJ; Ridker PM
Heart; 2008 Mar; 94(3):e13. PubMed ID: 17923463
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
13. Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension.
White WB; Punzi HA; Murwin D; Koval SE; Davidai G; Neutel JM
J Clin Hypertens (Greenwich); 2006 Sep; 8(9):626-33. PubMed ID: 16957424
[TBL] [Abstract][Full Text] [Related]
14. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
White WB; Davidai G; Schumacher H
J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
[TBL] [Abstract][Full Text] [Related]
15. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
Mallion JM; Carretta R; Trenkwalder P; Martinez JF; Tykarski A; Teitelbaum I; Oddou P; Fagan T;
Blood Press Suppl; 2003 May; 1():36-43. PubMed ID: 12800986
[TBL] [Abstract][Full Text] [Related]
16. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
17. Valsartan: more than a decade of experience.
Black HR; Bailey J; Zappe D; Samuel R
Drugs; 2009; 69(17):2393-414. PubMed ID: 19911855
[TBL] [Abstract][Full Text] [Related]
18. Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.
Ruilope LM; Zanchetti A
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S8-11. PubMed ID: 16986228
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
Sharma AM; Davidson J; Koval S; Lacourcière Y
Cardiovasc Diabetol; 2007 Oct; 6():28. PubMed ID: 17910747
[TBL] [Abstract][Full Text] [Related]
20. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
Karalliedde J; Smith A; DeAngelis L; Mirenda V; Kandra A; Botha J; Ferber P; Viberti G
Hypertension; 2008 Jun; 51(6):1617-23. PubMed ID: 18426991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
